AR034920A1 - Metodos para el tratamiento de enfermedades intestinales inflamatorias - Google Patents

Metodos para el tratamiento de enfermedades intestinales inflamatorias

Info

Publication number
AR034920A1
AR034920A1 ARP020102846A ARP020102846A AR034920A1 AR 034920 A1 AR034920 A1 AR 034920A1 AR P020102846 A ARP020102846 A AR P020102846A AR P020102846 A ARP020102846 A AR P020102846A AR 034920 A1 AR034920 A1 AR 034920A1
Authority
AR
Argentina
Prior art keywords
treatment
methods
intestinal diseases
inflammatory intestinal
inflammatory
Prior art date
Application number
ARP020102846A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Publication of AR034920A1 publication Critical patent/AR034920A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Las condiciones inflamatorias en la mucosa intestinal se previenen o tratan con una composición probiótica farmacéutica o dietaria que contiene Streptococci, Lactobacilli y Bifidobacteria protectores en una cantidad diaria de 10 a 3.600 x 10(9) células bacterianas.
ARP020102846A 2001-07-30 2002-07-29 Metodos para el tratamiento de enfermedades intestinales inflamatorias AR034920A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30811701P 2001-07-30 2001-07-30

Publications (1)

Publication Number Publication Date
AR034920A1 true AR034920A1 (es) 2004-03-24

Family

ID=23192625

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102846A AR034920A1 (es) 2001-07-30 2002-07-29 Metodos para el tratamiento de enfermedades intestinales inflamatorias

Country Status (3)

Country Link
AR (1) AR034920A1 (es)
AU (1) AU2002329043A1 (es)
WO (1) WO2003013558A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
WO2008064521A1 (fr) * 2006-11-30 2008-06-05 Pharmapep Research & Development (Shenzhen) Co., Ltd. Lactobacillus fermentum cms-h002 et son utilisation
JP5203393B2 (ja) * 2008-01-15 2013-06-05 サッポロビール株式会社 アルコール性肝障害抑制剤
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
EP2228067B1 (de) * 2010-02-22 2013-12-11 LR Health & Beauty Systems GmbH Probiotische Zusammensetzung und deren Verwendung
KR102157718B1 (ko) * 2010-07-26 2020-09-18 큐 바이올로직스 인코포레이티드 면역원성 소염 조성물
CN104398538A (zh) * 2014-10-28 2015-03-11 大连医科大学 一种用于减轻化疗副作用的复合益生菌制剂
WO2018112739A1 (zh) * 2016-12-20 2018-06-28 深圳华大基因研究院 一种假小链状双歧杆菌及其培养方法和应用
WO2019227414A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
CN111248443A (zh) * 2020-03-10 2020-06-09 安徽大学 一种具有改善溃疡性结肠炎的合生元组合物及其制剂与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1307850B1 (it) * 1999-03-15 2001-11-19 Italmed Di Galli Giovanna E Pa Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio

Also Published As

Publication number Publication date
AU2002329043A1 (en) 2003-02-24
WO2003013558A1 (en) 2003-02-20
WO2003013558A8 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
BR9916062A (pt) Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital
BRPI0615785B8 (pt) composição inibidora da absorção de colesterol compreendendo bactérias do gênero bifidobacterium
BR9910251A (pt) Estimulação hematopoiética
DE60115842D1 (de) Ventilanordnung
WO2002083879A3 (en) Immunotherapy based on dendritic cells
YU48600A (sh) Celekoksibne smese
NO954996L (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
DE69905368D1 (en) Oxydiertes thymosin beta 4
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
NO985980L (no) Lektinpreparater og anvendelser derav
ATE221783T1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
ATE333875T1 (de) Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod
WO2003080568A3 (en) Probucol derivatives
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie

Legal Events

Date Code Title Description
FA Abandonment or withdrawal